High-dose simvastatin exhibits enhanced lipid-lowering effects relative to simvastatin/ezetimibe combination therapy
about
Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the futureEzetimibe plus simvastatin for the treatment of hypercholesterolemia.Lovastatin reversed the enhanced sphingomyelin caused by 27-hydroxycholesterol in cultured vascular endothelial cells
P2860
High-dose simvastatin exhibits enhanced lipid-lowering effects relative to simvastatin/ezetimibe combination therapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
High-dose simvastatin exhibits ...... /ezetimibe combination therapy
@ast
High-dose simvastatin exhibits ...... /ezetimibe combination therapy
@en
High-dose simvastatin exhibits ...... /ezetimibe combination therapy
@nl
type
label
High-dose simvastatin exhibits ...... /ezetimibe combination therapy
@ast
High-dose simvastatin exhibits ...... /ezetimibe combination therapy
@en
High-dose simvastatin exhibits ...... /ezetimibe combination therapy
@nl
prefLabel
High-dose simvastatin exhibits ...... /ezetimibe combination therapy
@ast
High-dose simvastatin exhibits ...... /ezetimibe combination therapy
@en
High-dose simvastatin exhibits ...... /ezetimibe combination therapy
@nl
P2093
P2860
P50
P1476
High-dose simvastatin exhibits ...... /ezetimibe combination therapy
@en
P2093
Craig E Wheelock
Fabio Luiz D'Alexandri
Jesper Z Haeggström
Magnus Settergren
Matej Orešič
Stuart G Snowden
Theresa L Pedersen
P2860
P304
P356
10.1161/CIRCGENETICS.114.000606
P577
2014-12-01T00:00:00Z